Nightingale Health Oyj
NGHLF
$1.75
$0.000.00%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.19% | 3.93% | 8.35% | 19.09% | 35.54% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.19% | 3.93% | 8.35% | 19.09% | 35.54% |
| Cost of Revenue | 21.58% | -0.56% | -20.41% | 5.40% | 52.46% |
| Gross Profit | -6.43% | 5.87% | 22.88% | 24.76% | 30.14% |
| SG&A Expenses | 6.41% | 1.87% | -1.51% | -7.41% | -10.24% |
| Depreciation & Amortization | -11.24% | -5.30% | 2.24% | 7.16% | 15.41% |
| Other Operating Expenses | 33.39% | 33.14% | 34.43% | 13.77% | -1.57% |
| Total Operating Expenses | 6.41% | 5.47% | 5.70% | 2.61% | 2.46% |
| Operating Income | -7.81% | -5.85% | -5.08% | 0.90% | 3.86% |
| Income Before Tax | -16.17% | -10.79% | -6.63% | 0.95% | 5.28% |
| Income Tax Expenses | -30.20% | -35.35% | -39.12% | -1.56% | 116.67% |
| Earnings from Continuing Operations | -15.99% | -10.59% | -6.40% | 0.95% | 5.08% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -15.99% | -10.59% | -6.40% | 0.95% | 5.08% |
| EBIT | -7.81% | -5.85% | -5.08% | 0.90% | 3.86% |
| EBITDA | -12.40% | -1.01% | 9.16% | 10.78% | 9.36% |
| EPS Basic | -15.94% | -10.61% | -6.48% | 0.91% | 5.09% |
| Normalized Basic EPS | -16.20% | -10.85% | -6.67% | 0.86% | 5.06% |
| EPS Diluted | -15.94% | -10.61% | -6.48% | 0.91% | 5.09% |
| Normalized Diluted EPS | -16.20% | -10.85% | -6.67% | 0.86% | 5.06% |
| Average Basic Shares Outstanding | 0.02% | 0.02% | 0.01% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.02% | 0.02% | 0.01% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |